2
Registered trials
1
Recruiting
2
Unique sponsors
2
Unique IMPs
1
Commercial trials
Drug classes (ATC)
—
ATC code not specified
1
L
Oncology (ATC L)
1
Mechanism of action (INN-stem analysis)
Unknown / small molecule
1 substance
PARP inhibitor
1 substance
Phase IV:
1
Phase I (First in Human):
1
Phase IV
1 trial-
EndedMario Negri Institute For Pharmacological Research AcademicOLAPARIB
Phase I (First in Human)
1 trial-
RecruitingDaiichi Sankyo Inc. CommercialDS-3939A
Sponsor activity
| Sponsor | Type | Trials | Phases | Recruiting |
|---|---|---|---|---|
| Daiichi Sankyo Inc. | Commercial | 1 | Phase I (First in Human) | 1 |
| Mario Negri Institute For Pharmacological Research | Academic | 1 | Phase IV | 0 |
New trials by year
2023
1
2025
1